Home > Insider Trading > Filing (0001209191-21-049715)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610950	Syneos Health Inc.	SYNH	Services-Commercial Physical & Biological Research (8731)	273403111

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1624073	Alistair Macdonald	C/O Syneos Health, Inc. 1030 Sync Street Morrisville NC 27560	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2021-08-02	4,710	$89.90	195,760	No	4	S	Direct
Class A Common Stock	Acquisiton	2021-08-03	35,553	$42.76	231,313	No	4	M	Direct
Class A Common Stock	Disposition	2021-08-03	28,521	$87.83	202,792	No	4	S	Direct
Class A Common Stock	Disposition	2021-08-03	7,032	$88.49	195,760	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	Disposition	2021-08-03	35,553	$0.00	35,553	$42.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-08-01	No	4	M	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2020.
The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $87.28 to $88.27, inclusive. The reporting person undertakes to provide Syneos Health, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $88.28 to $88.87, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares subject to this option vested in four approximately equal annual installments on August 1, 2017; August 1, 2018; August 1, 2019; and August 1, 2020.